In the trial, people with severe tricuspid regurgitation (TR) showed a significant reduction in recurrent HF hospitalizations 2 years after tricuspid TEER with the TriClip G4 (0.19 vs 0.26 events ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial’s ...

Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany (P.M.D., L.T.W., L.S., C.E., J.H.). Munich Heart Alliance, Partner Site ...

Mitral repair with annuloplasty for moderate ischemic mitral regurgitation in people undergoing coronary artery bypass surgery (Protocol). Cochrane Database of Systematic Reviews 2025, Issue 3. Art.